Norwegian Institute of Public Health
Oslo, 0213, Norway
NCT Number: NCT05690516
In this trial the researchers plan to recruit 4,000 volunteers to be randomly allocated either wearing face masks in public spaces where they are close to other people, or not wear face masks in such circumstances. For each participant the trial period is 2 weeks, after which they will be asked to complete a brief questionnaire which includes questions about whether they experienced the common cold, influenzas or COVID-19 symptoms during the trail period.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Oslo, 0213, Norway
This study is a pragmatic, two-armed cluster randomized superiority trial including participants in Norway. Participants will be randomized to one of the following two arms: control group or medical masks in a 1:1 ratio. The primary outcome is self-reported respiratory infection.
The intervention is to ask participants in the intervention groups to wear face masks when close to others outside their home, e.g., in public spaces like shopping centres, and streets and on public transport. The control group will be asked not to wear face masks when close to others outside their home, e.g., in public spaces like shopping centres, and streets and on public transport. Participants will continue to use, or not use, face masks at work independent of which group they are allocated to.
The trial will be fully remote and without any personal interaction between investigators and participants.
The researchers aim to include about 4,000 participants to have a statistical power of 80% to detect a relative risk reduction of 30% for the primary outcome.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants are asked to wear face masks in public spaces.
Time frame: Day 1 to 17
Self-report
Time frame: Day 1 to 17
Self-report
Time frame: Day 3 to 17 after start of tiral period
We will compare the incidence of notified cases of COVID-19 (i.e. registered positive SARS-CoV-tests)
Time frame: Day 1 to 17
Self-report
Time frame: Day 1 to 17
Self-report
Time frame: Day 1 to 17
Self-report
Norwegian Institute of Public Health
Other Gov
The Protective Effect of Mask Wearing Against Respiratory Tract Infections: a Pragmatic Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05321433
COVID-19, Coronaviridae Infections
Solna, Stockholm County, Sweden
View Trial DetailsNCT05217797
COVID-19, Coronaviridae Infections
Oslo, Norway
View Trial DetailsNCT05156723
COVID-19, Coronaviridae Infections
Moscow, Russia
View Trial DetailsNCT04326309
Asthma, Bronchial Diseases
The Bronx, New York, United States
View Trial Details